skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Since the last question on PTK, it seems to go up and up. Has anything changed? Has 5is opinion changed?


They won "Best in Artificial intelligence" in the "Global Tech Awards". Does this mean anything? Looking at the judges for this organization, there does appear to be some people with some clout in there, but scrutinizing it a bit it seems to be very much marketing focused, and with 86 categories and 200 companies, not the broadest competition.

It looks like it spikes every couplefew months, followed by up to 20% retreat, and spikes again. I almost feel like swing trading this or something.

With your recent small cap likes, PNG, MDA, ZDC, and BRM, Would you please Rank them from best to worst with a solid entry price (I know you said MDA is good right now), expected growth for 2025, whether they're profitable (yes, no, or close), and a score of 1 - 10. (1 being moonshot, 10 Solid buy). IE {NVDA, profitable X%, 10} sort of thing.

All of these scores exclude the normal smallcap risks etc (i understand that MDA is considerably larger, and is primarily in here for comparison purposes)

Thanks a tonne, James
Read Answer Asked by James on November 29, 2024
Q: Peter and His Wonder Team
I have held this stock for too long...if you know what I mean! Ha!Ha! The good news is that I am now even and thinking about selling. However some analysts have a 100% up side forecast which I know is only a forecast. Please...I appreciate your objective opinion. Sell because there are better opportunities...or it is worth waiting another quarter two?
Thanks as always!
Read Answer Asked by Ernest on November 29, 2024
Q: This company has run up quite a bit with a very strong RSI rating >80 so would it be wiser to wait for a pull back or buy a small portion here? Hard to answer as I know timing can't be perfect.

Lots of tailwinds for the 'security' sector and ability to use onsite cameras to do other things (eg manage project status updates, onsite manpower etc) so do you consider this a buy? What risks do you foresee in its business model as I realise small cap sizing and YTD large gains can be potential headwinds.

Thanks as always!
Read Answer Asked by Cathy on November 29, 2024
Q: Your analysis on the prospects of Nurix will be greatly appreciated.

Thanks
thomas
Read Answer Asked by Thomas on November 27, 2024
Q: Hello Team,

My TFSA is currently not getting the returns I'm hoping for, can you please rank the above companies to purchase today in a TFSA account.

Also if you feel strongly about any other high growth stocks I'm missing pls include 2 or 3 additional ideas.

Thanks!
Read Answer Asked by Kevin on November 27, 2024
Q: Hi 5i Team,

It seems like your current view, including from your monthly commentary, is that small and mid caps are continuing to look attractive and the forward returns are historically attractive after past US elections. With this in mind, something I struggle with is a large proportion of my portfolio is in large cap stocks, including 10% of my portfolio in NVDA. A lot of this is due to the strength in large caps since 2022 and my bias has been to continue to hold them at a higher percentage as they have provided strong returns over the past few years. Although, these large caps, including NVDA continue to grow and execute my feeling is that I should trim stocks like NVDA down to 5% and use those excess proceeds to invest further funds into small and mid caps to potentially capitalize on the large gap in valuations between small and mid caps and other tailwinds like declining interest rates. For a growth investor with 20+ years of investment horizon would you recommend going the route of trimming NVDA and other large cap winners to a 5% portfolio weight and re-allocate into small and mid caps?

Thanks as always,
Jon
Read Answer Asked by Jonathan on November 27, 2024